Human Activin Receptor Type IIA (ACVR2A) activation kit by CRISPRa

CAT#: GA100058

ACVR2A CRISPRa kit - CRISPR gene activation of human activin A receptor type 2A

  See Other Versions


Find the corresponding CRISPRi Inhibitor Kit

USD 1,290.00

2 Weeks*

Size
    • 1 kit

Product Images

Frequently bought together (2)
Rabbit Polyclonal antibody to Activin A Receptor type IIA (activin A receptor, type IIA)
    • 100 ul

USD 415.00


qSTAR qPCR primer pairs against Homo sapiens gene ACVR2A
    • 200 reactions

USD 120.00

Other products for "ACVR2A"

Specifications

Product Data
Format 3gRNAs, 1 scramble ctrl and 1 enhancer vector
Symbol ACVR2A
Locus ID 92
Kit Components

GA100058G1, Activin Receptor Type IIA gRNA vector 1 in pCas-Guide-GFP-CRISPRa

GA100058G2, Activin Receptor Type IIA gRNA vector 2 in pCas-Guide-GFP-CRISPRa

GA100058G3, Activin Receptor Type IIA gRNA vector 3 in pCas-Guide-GFP-CRISPRa

1 CRISPRa-Enhancer vector, SKU GE100056

1 CRISPRa scramble vector, SKU GE100077

Disclaimer The kit is designed based on the best knowledge of CRISPa SAM technology. The efficiency of the activation can be affected by many factors, including nucleosome occupancy status, chromatin structure and the gene expression level of the target, etc.
Reference Data
RefSeq NM_001278579, NM_001278580, NM_001616
Synonyms ACTRII; ACVR2
Summary 'This gene encodes a receptor that mediates the functions of activins, which are members of the transforming growth factor-beta (TGF-beta) superfamily involved in diverse biological processes. The encoded protein is a transmembrane serine-threonine kinase receptor which mediates signaling by forming heterodimeric complexes with various combinations of type I and type II receptors and ligands in a cell-specific manner. The encoded type II receptor is primarily involved in ligand-binding and includes an extracellular ligand-binding domain, a transmembrane domain and a cytoplasmic serine-threonine kinase domain. This gene may be associated with susceptibility to preeclampsia, a pregnancy-related disease which can result in maternal and fetal morbidity and mortality. Alternative splicing results in multiple transcript variants of this gene. [provided by RefSeq, Jun 2013]'

Other Versions

{0} Product Review(s)

0 Product Review(s) Submit review

Be the first one to submit a review

Product Citations

*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.